This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Raqualia Pharma Inc.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Makiko Kuroda: Innovator in Ghrelin Receptor Agonists
Introduction
Makiko Kuroda is a prominent inventor based in Aichi, Japan. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that act as ghrelin receptor agonists. With a total of 2 patents to her name, Kuroda's work is paving the way for new therapeutic options.
Latest Patents
Kuroda's latest patents include innovative compounds designed to modulate the growth hormone secretagogue receptor, also known as the ghrelin receptor. The first patent focuses on tetrahydropyrazolopyridine derivatives, which are novel compounds that can be used in therapy for disorders mediated by the ghrelin receptor. The second patent involves serine derivatives, which also serve as ghrelin receptor agonists, highlighting her commitment to advancing medical science through her research.
Career Highlights
Throughout her career, Kuroda has demonstrated a strong dedication to her field. Her work at Raqualia Pharma Inc. has allowed her to collaborate with other talented professionals and contribute to groundbreaking research.
Collaborations
Kuroda has worked alongside esteemed colleagues such as Yasuhiro Iwata and Kiyoshi Kawamura. Their combined expertise has fostered an environment of innovation and discovery.
Conclusion
Makiko Kuroda's contributions to the field of pharmaceutical sciences, particularly in the area of ghrelin receptor agonists, underscore her role as a leading inventor. Her patents reflect her innovative spirit and commitment to improving therapeutic options for various disorders.